Evidence map›Paper›PMID 30981733›Full record

ArticleJournal of molecular and cellular cardiology2019

Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy.

Bereketeab Haileselassie, Riddhita Mukherjee, Amit U Joshi, Brooke A Napier, Liliana M Massis, Nicolai Patrick Ostberg, Bruno B Queliconi, Denise Monack, Daniel Bernstein, Daria Mochly-Rosen

Erratum issuedAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. mRedox biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bereketeab HaileselassieDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: bhailes3@stanford.edu.
Riddhita MukherjeeDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Amit U JoshiDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Brooke A NapierDepartment of Microbiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Liliana M MassisDepartment of Microbiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Nicolai Patrick OstbergDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Bruno B QueliconiDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Denise MonackDepartment of Microbiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Daniel BernsteinDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Daria Mochly-RosenDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Stanford University · US

Funding

Pediatric Critical Care Scientist Development ProgramK12HD047349 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HEATHER T. KEENAN, Kevin M Watt · 2004 to 2026
$17.0M
Protein Kinase C Isozymes in Ischemic HeartR01HL052141 · NHLBI · STANFORD UNIVERSITY · PI MOCHLY-ROSEN, DARIA · 1996 to 2021
$8.5M
MECHANISMS OF ETHANOL-INDUCED CARDIAC PROTECTIONR01AA011147 · NIAAA · STANFORD UNIVERSITY · PI DARIA MOCHLY-ROSEN · 1996 to 2026
$8.2M
Dysregulation of Mitochondrial Dynamics in Sepsis R00HD099387 · NICHD · STANFORD UNIVERSITY · PI HAILESELASSIE, BEREKETAB · 2021 to 2023
$747k
Dysregulation of Mitochondrial Dynamics in Sepsis Induced Multi-Organ Dysfunction Syndrome (MODS)K99HD099387 · NICHD · STANFORD UNIVERSITY · PI HAILESELASSIE, BEREKETAB · 2020 to 2020
$132k
NHLBI NIH HHS R01 HL052141NICHD NIH HHS K12 HD047349NICHD NIH HHS K99 HD099387NICHD NIH HHS R00 HD099387
6 · The paper itself

Abstract

Mitochondrial dysfunction is a key contributor to septic cardiomyopathy. Although recent literature implicates dynamin related protein 1 (Drp1) and its mitochondrial adaptor fission 1 (Fis1) in the development of pathologic fission and mitochondrial failure in neurodegenerative disease, little is known about the role of Drp1/Fis1 interaction in the context of sepsis-induced cardiomyopathy. Our study tests the hypothesis that Drp1/Fis1 interaction is a major driver of sepsis-mediated pathologic fission, leading to mitochondrial dysfunction in the heart.

methodsH9C2 cardiomyocytes were treated with lipopolysaccharide (LPS) to evaluate changes in mitochondrial membrane potential, oxidative stress, cellular respiration, and mitochondrial morphology. Balb/c mice were treated with LPS, cardiac function was measured by echocardiogaphy, and mitochondrial morphology determined by electron microscopy (EM). Drp1/Fis1 interaction was inhibited by P110 to determine whether limiting mitochondrial fission can reduce LPS-induced oxidative stress and cardiac dysfunction.

resultsLPS-treated H9C2 cardiomyocytes demonstrated a decrease in mitochondrial respiration followed by an increase in mitochondrial oxidative stress and a reduction in membrane potential. Inhibition of Drp1/Fis1 interaction with P110 attenuated LPS-mediated cellular oxidative stress and preserved membrane potential. In vivo, cardiac dysfunction in LPS-treated mice was associated with increased mitochondrial fragmentation. Treatment with P110 reduced cardiac mitochondrial fragmentation, prevented decline in cardiac function, and reduced mortality.

conclusionsSepsis decreases cardiac mitochondrial respiration and membrane potential while increasing oxidative stress and inducing pathologic fission. Treatment with P110 was protective in both in vitro and in vivo models of septic cardiomyopathy, suggesting a key role of Drp1/Fis1 interaction, and a potential target to reduce its morbidity and mortality.

Indexed as

Mitochondrial DynamicsAnimalsCardiomyopathiesCell LineDynaminsFemaleLipopolysaccharidesMiceMice, Inbred BALB CMitochondria, HeartMitochondrial ProteinsOxidative StressRatsSepsisDnm1l protein, mouseDynaminsFIS1 protein, mouseLipopolysaccharidesMitochondrial ProteinsDrp1Heart failureMitochondrial fissionSepsis

Identifiers

PMID30981733
PMCPMC6948926
OpenAlexW2936317983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.